Reducing the Amyloidogenicity of Functional Amyloid Protein FapC Increases Its Ability To Inhibit α-Synuclein Fibrillation

Functional amyloid (FA) proteins have evolved to assemble into fibrils with a characteristic cross-beta structure, which stabilizes biofilms and contributes to bacterial virulence. Some of the most studied bacterial FAs are the curli protein CsgA, expressed in a wide range of bacteria, and FapC, produced mainly by members of the Pseudomonas genus. Though unrelated, both CsgA and FapC contain imperfect repeats believed to drive the formation of amyloid fibrils. While much is known about CsgA biogenesis and fibrillation, the mechanism of FapC fibrillation remains less explored. Here, we show that removing the three imperfect repeats of FapC (FapC Delta R1R2R3) slows down the fibrillation but does not prevent it. The increased lag phase seen for FapC Delta R1R2R3 allows for disulfide bond formation, which further delays fibrillation. Remarkably, these disulfide-bonded species of FapC Delta R1R2R3 also significantly delay the fibrillation of human alpha-synuclein, a key protein in Parkinson's disease pathology. This attenuation of alpha-synuclein fibrillation was not seen for the reduced form of FapC Delta R1R2R3. The results presented here shed light on the FapC fibrillation mechanism and emphasize how unrelated fibrillation systems may share such common fibril formation mechanisms, allowing inhibitors of one fibrillating protein to affect a completely different protein.